本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR
Foresite Capital Management III, LLC (CIK 1645157) reported $37.9M across 4 reported positions in its SEC 13F filing for 2022-09-30. Largest positions: ASND ($13.8M, 36.44%), VRNA ($11.4M, 29.98%), NTRA ($7.0M, 18.41%), CBAY ($5.7M, 15.17%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | $13.8M | 36.44% | 133,691 | Hold |
| 2 | VRNA | Verona Pharma PLC. | $11.4M | 29.98% | 1.1M | Hold |
| 3 | NTRA | Natera, Inc. | $7.0M | 18.41% | 159,160 | Hold |
| 4 | CBAY | Cymabay Therapeutics, Inc. | $5.7M | 15.17% | 1.6M | Hold |
来源：SEC 13F 申报文件 · 截至 2022-09-30